{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:05:47Z","timestamp":1779879947408,"version":"3.53.1"},"reference-count":40,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:00:00Z","timestamp":1778976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Papillary thyroid microcarcinoma (PTMC) is generally indolent; however, a subset exhibits aggressive features, reflecting biological heterogeneity. In the era of treatment de-escalation and active surveillance, accurate risk stratification is essential. We aimed to evaluate recurrence, identify factors associated with recurrence, determine predictors of lymph node metastasis (LNM) at diagnosis, and assess management strategies at our center. Materials and Methods: This retrospective study included 302 patients with PTMC. Associations between clinicopathological variables and outcomes were evaluated using chi-square test, Spearman correlation, and univariate and multivariate logistic regression analyses. Results: The cohort included 240 females (79.5%) and 62 males (20.5%), with a median age of 47 years. Total thyroidectomy was performed in 97.7%, and radioactive iodine (RAI) in 64.2%. LNM was identified in 26 patients (8.6%). Recurrence occurred in 4 patients (1.3%), and 98.0% were alive at last follow-up. Recurrence was associated with LNM at diagnosis, higher ATA risk categories, and positive surgical margins (p &lt; 0.005). Younger age, larger tumor size, and vascular invasion independently predicted LNM (all p &lt; 0.05), while autoimmune thyroiditis was associated with a reduced risk (p = 0.020). Conclusions: PTMC demonstrates clinically relevant heterogeneity, particularly in patients with LNM. However, given the limited number of recurrence events, recurrence-related findings should be interpreted cautiously and considered exploratory. These findings support risk-adapted management and careful patient selection in the era of treatment de-escalation.<\/jats:p>","DOI":"10.3390\/medicina62050981","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:19:52Z","timestamp":1779877192000},"page":"981","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Factors and Recurrence in Papillary Thyroid Microcarcinoma"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8504-4798","authenticated-orcid":false,"given":"Aydan","family":"Farzaliyeva","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Baskent University, 06490 Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6790-3031","authenticated-orcid":false,"given":"Feride P\u0131nar","family":"Altay","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolic Diseases, Ankara Bilkent City Hospital, 06800 Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5305-6807","authenticated-orcid":false,"given":"Ozlem","family":"Turhan Iyidir","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolic Diseases, Faculty of Medicine, Baskent University, 06490 Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan","family":"Bascil Tutuncu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolic Diseases, Faculty of Medicine, Baskent University, 06490 Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,17]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"El Hag, I.A., and Tallab, R. (2025). Papillary thyroid carcinoma measuring 1.0 cm or less: An epidemiological and clinicopathological study. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1678065"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1089\/thy.2022.0109","article-title":"Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy","volume":"32","author":"Papachristos","year":"2022","journal-title":"Thyroid Off. J. Am. Thyroid Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1001\/jamaoncol.2022.3875","article-title":"Expanded Parameters in Active Surveillance for Low-risk Papillary Thyroid Carcinoma: A Nonrandomized Controlled Trial","volume":"8","author":"Ho","year":"2022","journal-title":"JAMA Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3803\/EnM.2024.1937","article-title":"Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines","volume":"39","author":"Kim","year":"2024","journal-title":"Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Li, Y., Tian, J., Jiang, K., Wang, Z., Gao, S., Wei, K., Yang, A., and Li, Q. (2023). Risk factors and predictive model for recurrence in papillary thyroid carcinoma: A single-center retrospective cohort study based on 955 cases. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1268282"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/thy.2023.0076","article-title":"Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience","volume":"33","author":"Miyauchi","year":"2023","journal-title":"Thyroid Off. J. Am. Thyroid Assoc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e230495","DOI":"10.20945\/2359-4292-2023-0495","article-title":"Active surveillance of papillary thyroid carcinoma in Latin America: A scoping review","volume":"68","author":"Manfio","year":"2024","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3803\/EnM.2025.2461","article-title":"2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma","volume":"40","author":"Lee","year":"2025","journal-title":"Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid Off. J. Am. Thyroid Assoc."},{"key":"ref_11","first-page":"148","article-title":"Active Surveillance for Low-Risk Differentiated Thyroid Cancer","volume":"29","author":"Ahmadi","year":"2023","journal-title":"Endocr. Pract. Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.23736\/S2724-6507.22.03749-6","article-title":"Papillary thyroid carcinoma: The impact of histologic vascular invasion","volume":"49","author":"Fonseca","year":"2024","journal-title":"Minerva Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1055\/s-0040-1722253","article-title":"Predictive Factors of Recurrence of Papillary Thyroid Microcarcinomas: Analysis of 2,538 Patients","volume":"25","author":"Carvalho","year":"2021","journal-title":"Int. Arch. Otorhinolaryngol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Dias, F.A., de Souza, R.P., Briaunys Milan, T., and De Cicco, R. (2025). Structural recurrence in well-differentiated papillary thyroid carcinoma: A 10-year single center cohort study. Oncol. Rev., 19.","DOI":"10.3389\/or.2025.1638499"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"572526","DOI":"10.2147\/CMAR.S572526","article-title":"Risk Stratification in Papillary Thyroid Microcarcinoma: Clinical Features Predicting Multifocality, Lymph Node Metastasis, and Recurrence\u2014A Retrospective Cohort Study","volume":"18","author":"Hsu","year":"2026","journal-title":"Cancer Manag. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00428-025-04312-1","article-title":"Nodal metastases in papillary thyroid microcarcinoma: Prevalence and risk factors in 311 patients","volume":"488","author":"Lai","year":"2026","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chiu, Y.H., Wu, S.T., Chen, Y.N., Chen, W.C., Lim, L.S., Chiew, Y.E.W., Kuo, P.C., Yang, Y.C., Chi, S.Y., and Chou, C.K. (2025). Analysis of Risk Factors for High-Risk Lymph Node Metastasis in Papillary Thyroid Microcarcinoma. Cancers, 17.","DOI":"10.3390\/cancers17152585"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Medas, F., Canu, G.L., Cappellacci, F., Boi, F., Lai, M.L., Erdas, E., and Cal\u00f2, P.G. (2020). Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00551"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13044-025-00224-z","article-title":"The impact of age at diagnosis on central lymph node metastasis in clinically low-risk papillary thyroid microcarcinoma patients","volume":"18","author":"Liu","year":"2025","journal-title":"Thyroid. Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Qiu, P., Guo, Q., Pan, K., and Lin, J. (2024). Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12004-3"},{"key":"ref_21","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA A Cancer J. Clin."},{"key":"ref_22","first-page":"625","article-title":"Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study","volume":"102","author":"Hwangbo","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Gjeloshi, B., Rossi, L., Ambrosini, C.E., Becucci, C., Papini, P., Palma, A., De Napoli, L., Puccini, M., and Materazzi, G. (2026). Evolving Practices in Low-Risk Papillary Thyroid Cancer: Impact of the 2015 ATA Guidelines. Curr. Oncol. (Tor. Ont.), 33.","DOI":"10.3390\/curroncol33010026"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/cam4.3743","article-title":"Which is preferred for initial treatment of papillary thyroid cancer, total thyroidectomy or lobotomy?","volume":"10","author":"Wu","year":"2021","journal-title":"Cancer Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhang, T., He, L., Wang, Z., Dong, W., Sun, W., Zhang, P., and Zhang, H. (2021). The Differences Between Multifocal and Unifocal Papillary Thyroid Carcinoma in Unilateral Lobe: A Meta-Analysis. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.657237"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Bilgic, S., Meral, R., Sa\u011fer, M.S., and S\u00f6nmezo\u011flu, K. (2024). RAI therapy in low-risk papillary thyroid cancer: Recurrence reduction and long-term outcomes in the Turkish population. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12986-0"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jamaoto.2021.1976","article-title":"Association of Multifocality With Prognosis of Papillary Thyroid Carcinoma: A Systematic Review and Meta-analysis","volume":"147","author":"Kim","year":"2021","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Violetis, O., Sfakiotaki, M., Spyroglou, A., Pissadaki, E., Iliakopoulos, K., Syntzanaki, E.K., Konstantakou, P., Chouliara, E., Nastos, C., and Dafnios, N. (2025). Predictive Factors of Lymph Node Metastasis in Papillary Thyroid Microcarcinoma (PTMC). Medicina, 61.","DOI":"10.3390\/medicina61101800"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Mao, J., Zhang, Q., Zhang, H., Zheng, K., Wang, R., and Wang, G. (2020). Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00265"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"45288","DOI":"10.1038\/s41598-025-28483-8","article-title":"Personalized prediction of lymph node metastasis in papillary thyroid microcarcinoma: A nomogram and web calculator","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/wjs.12551","article-title":"Active Surveillance for Low-Risk Papillary Thyroid Microcarcinoma in China: A Prospective Study on Progression, Influencing Factors, and Cost-Effectiveness","volume":"49","author":"Ge","year":"2025","journal-title":"World J. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1089\/thy.2021.0614","article-title":"Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea","volume":"32","author":"Lee","year":"2022","journal-title":"Thyroid Off. J. Am. Thyroid Assoc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e230422","DOI":"10.20945\/2359-4292-2023-0422","article-title":"Prognostic factors for aggressiveness in subcentimeter papillary thyroid carcinoma: Impact of tumor size and lymph node metastases","volume":"68","author":"Kayhan","year":"2024","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Huang, H., Xu, S., Ni, S., Wang, X., and Liu, S. (2023). A nomogram for predicting lateral lymph node metastasis in cN0 unifocal papillary thyroid microcarcinoma. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-11219-0"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s12672-025-02789-5","article-title":"Global research landscape on active surveillance for papillary thyroid microcarcinoma: A bibliometric analysis","volume":"16","author":"Kang","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e230006","DOI":"10.1148\/radiol.230006","article-title":"US Predictors of Papillary Thyroid Microcarcinoma Progression at Active Surveillance","volume":"309","author":"Lee","year":"2023","journal-title":"Radiology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12957-025-04184-4","article-title":"The dual oncogenic and protective roles of hashimoto\u2019s thyroiditis in papillary thyroid carcinoma: A cohort-based meta-analysis","volume":"24","author":"Ma","year":"2026","journal-title":"World J. Surg. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Yao, S., and Zhang, H. (2025). Papillary thyroid carcinoma with Hashimoto\u2019s thyroiditis: Impact and correlation. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1512417"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"15525","DOI":"10.1007\/s00432-023-05332-7","article-title":"Hashimoto\u2019s thyroiditis is negatively associated with lymph node metastasis in PTMC","volume":"149","author":"Huang","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5114\/pjp.2022.124486","article-title":"Risk factors for central lymph node metastasis in papillary thyroid microcarcinoma\u2014A retrospective study of 1433 cases from a single center","volume":"73","author":"Shen","year":"2022","journal-title":"Pol. J. Pathol. Off. J. Pol. Soc. Pathol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/981\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:30:47Z","timestamp":1779877847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,17]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["medicina62050981"],"URL":"https:\/\/doi.org\/10.3390\/medicina62050981","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,17]]}}}